Dimensional Fund Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Dimensional Fund Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-77,775	Closed	-$1.87M	–	3564
2023 Q1	$1.87M	Buy	77,775 +1,666	+2%	+$20.9K	﹤0.01%	2757
2022 Q4	$804	Sell	76,109 -472	-0.6%	-$3.81K	﹤0.01%	2947
2022 Q3	$344K	Sell	76,581 -3,461	-4%	-$15.8K	﹤0.01%	3127
2022 Q2	$320K	Buy	80,042 +47,911	+149%	+$227K	﹤0.01%	3166
2022 Q1	$235K	Hold	32,131	–	–	﹤0.01%	3288
2021 Q4	$181K	Buy	+32,131	New	+$204K	﹤0.01%	3359

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors's PRVB Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 77,775 shares — an estimated $1.87M sold.

Dimensional Fund Advisors first reported a position in PRVB in Q4 2021 and held it in 6 quarters. The position peaked at $1.87M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Dimensional Fund Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 77,775 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.87M.
Dimensional Fund Advisors first reported a position in Provention Bio, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Dimensional Fund Advisors's Provention Bio, Inc. Common Stock position peaked at $1.87M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.